Today Is An Important Day For The ExOne Company (XONE)

The ExOne Company (NASDAQ:XONE) could be one of the worst stocks that investors may not want to consider for their portfolio today as the company shares are trading 4.26% or 0.31 points down from last closing price of $7.28, reaching $6.97 at last check. Any clue why there is so much of action in the XONE stock? The share price has dropped in 3 of the last 5 days and is down -31.13% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on solid volume too with far more shares changing hands than in a normal session. Trading activity as of this writing strengthened by 93,373 shares, and in total 226773 shares valued at $1.581 million were seen changing hands compared with 133400 shares valued at $971152 recorded at the previous session. You should take into consideration that a greater volume on lower prices causes the situation where nobody wants to continue with their long position and wants to exit from the XONE stock.

The ExOne Company (XONE) shares have notched a 3-month decline of about -31.13%, but has still advanced 9.97% year to date. By comparison, the stock added 3.41% over the past 12 months, while it slipped -12.18% over the 1 month. The company’s market cap is around $116.99M, with its short interest ratio standing at 21.03%.

In the current trading session for XONE, the stock witnessed two major price actions, it rose to a high of $7.33 and was down as much as $6.8 at one point. The high recorded is very low when compared to their 52-week high which is $5.73. The 52-week high is now at -39.98 distance from current price. Their recent low of $11.73 represents a 22.78% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for XONE is $13, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

The stock of The ExOne Company earned $-0.67 per share in the trailing 12 months and has a P/E ratio of -10.4. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 9.13 and lower compared to the sector’s average of 23. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. XONE also has P/S multiple of 1.8. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 0.55x.

The company recorded an interesting insider purchase transaction by the Director on May 20, 2019. A Securities and Exchanges Commission filings show that Roger William Thiltgen bought a total of 10,000 XONE shares that day for a sum of around $81,000. The filings show that the insider stake has now grown to 17,600 shares, currently worth $122,672. The ExOne Company (XONE) insiders have acquired 61,222 shares in the stock within the past three months. The total insider sales reported to the SEC in that time frame amounted to 5,995 shares. In total, individual insiders traded 67,217 shares in the business, which makes up 45.783% of 146,817 shares that were traded over a year. In the past 12 months, insiders have purchased 133,222 shares while the seller parted with 13,595 shares.

XONE‘s last price was down -18.25% as compared to the average trading price of 50 days recorded at $8.53 while enlarging the period to 200 trading days, the average closing price was $8.24. At present, there are 16.07 million in the total number of common shares owned by the public and among those 11.19 million shares have been available to trade. The percentage of shares being held by the company management was 2% while institutions stake was 31.6%. The company has generated negative returns on equity over the last 12 months (-17.9%). It managed to keep its gross profit margin at 33.6% over the past 12 months.

When assessing the full upside of the XONE stock, there is another set of technicals that should be looked into and considered. Its -10.42% decline from moving average of $7.78 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 3.47 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of The ExOne Company — 2 analysts rate the stock as a buy with another 0 rating it strong buy. There are 0 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $11.5 on shares of The ExOne Company (NASDAQ:XONE), which corresponds to 63.12% upside potential than its current market price of $6.97 and implies potential despite the recent drop in the price. However, their current target price has fallen from $11.5 a month ago and is down handily from the consensus target of $11.5 a quarter ago.

In the last five years, the EPS of the company has been roughly -8.8%. Though the percentage looks disappointing, extra tailwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will increase annually by 46.49%. The revenue of the company has risen at an average annualized rate of about 10.4 over the last five years. The company recently recorded a drop of -19.3%, but this figure is rather unattractive.

Let’s briefly check the hedge fund interest towards XONE stock. BlueCrest Capital Management Ltd added position in the company after it grew 50% or 11,000 shares of its common stock. The hedge fund now owns 16,500 shares worth $115,005, SEC documents show. Morgan Stanley shored up assets in the stock as 147959.2 shares have been purchased, increasing its stake by 49.4% to 221,051 shares which are currently valued at $1,540,725. In addition, ExodusPoint Capital Management LP recently reported that it now owns 20,940 shares making a total of $145,952 based on the recent price. This refelects a change of 50% in their ownership.